SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061921
Filing Date
2023-11-09
Accepted
2023-11-09 15:22:48
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20230930.htm   iXBRL 10-Q 2320495
2 EX-31.1 etnb-ex31_1.htm EX-31.1 16847
3 EX-31.2 etnb-ex31_2.htm EX-31.2 16859
4 EX-32 etnb-ex32.htm EX-32 18306
  Complete submission text file 0000950170-23-061921.txt   8321283

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT etnb-20230930_cal.xml EX-101.CAL 51352
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT etnb-20230930.xsd EX-101.SCH 52076
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT etnb-20230930_def.xml EX-101.DEF 189031
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT etnb-20230930_pre.xml EX-101.PRE 321859
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT etnb-20230930_lab.xml EX-101.LAB 470932
51 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20230930_htm.xml XML 1474975
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 231391966
SIC: 2834 Pharmaceutical Preparations